Health

CBAC is embarking on a major analysis of this institutional transformation imperative and, by next autumn, intends to provide strategic advice to government on the more immediate issues and opportunities. CBAC will also inform federal Ministers of the major topics, background analysis, consultation processes and partnerships it intends to pursue in developing advice on the longer-term institutional transformations required to achieve the goals of:

• ensuring Canadians capture the economic, social, health care, environmental, and quality of life benefits from biotechnology; and,
• addressing and managing the potential challenges, risks, hazards, tensions and tradeoffs associated with this transformative technology.

Biotechnology and Canadian Innovation

The discussion document Biotechnology and Health Innovation: Opportunities and Challenges has been prepared by the Canadian Biotechnology Advisory Committee (CBAC) as the first phase of a two-phase project on the role of biotechnology in health innovation (the BHI Project). We are eager to receive comments by June 30, 2004. Our contact information is:

Canadian Biotechnology Advisory Committee (CBAC)
255 Albert Street, 10^th Floor
Ottawa Ontario K1A 0H5

Toll free: 1 866 748-CBAC (2222)
TTY: 1 866 835-5380
Fax: (613) 946-2847
Web: www.cbac-cccb.ca
E-mail: info@cbac-cccb.ca

Biotechnology and Health Innovation: Opportunities and Challenges (PDF Format, 281 KB)